Regeneron Pharmaceuticals Inc (REGN)
906.54
-0.78
(-0.09%)
USD |
NASDAQ |
Apr 24, 16:00
910.00
+3.46
(+0.38%)
Pre-Market: 08:47
Regeneron Pharmaceuticals Free Cash Flow: 3.668B for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.668B |
| September 30, 2023 | 4.359B |
| June 30, 2023 | 3.004B |
| March 31, 2023 | 2.527B |
| December 31, 2022 | 3.398B |
| September 30, 2022 | 4.148B |
| June 30, 2022 | 7.869B |
| March 31, 2022 | 7.936B |
| December 31, 2021 | 6.529B |
| September 30, 2021 | 5.381B |
| June 30, 2021 | 1.694B |
| March 31, 2021 | 2.029B |
| December 31, 2020 | 2.004B |
| September 30, 2020 | 1.582B |
| June 30, 2020 | 2.425B |
| March 31, 2020 | 1.706B |
| December 31, 2019 | 2.000B |
| September 30, 2019 | 1.995B |
| June 30, 2019 | 1.906B |
| March 31, 2019 | 2.095B |
| December 31, 2018 | 1.812B |
| September 30, 2018 | 1.628B |
| June 30, 2018 | 1.636B |
| March 31, 2018 | 1.268B |
| December 31, 2017 | 1.034B |
| Date | Value |
|---|---|
| September 30, 2017 | 815.17M |
| June 30, 2017 | 992.46M |
| March 31, 2017 | 1.339B |
| December 31, 2016 | 974.00M |
| September 30, 2016 | 838.08M |
| June 30, 2016 | 1.052B |
| March 31, 2016 | 809.63M |
| December 31, 2015 | 652.85M |
| September 30, 2015 | 629.44M |
| June 30, 2015 | -32.77M |
| March 31, 2015 | 214.84M |
| December 31, 2014 | 419.43M |
| September 30, 2014 | 551.55M |
| June 30, 2014 | 527.76M |
| March 31, 2014 | 355.93M |
| December 31, 2013 | 432.27M |
| September 30, 2013 | 297.54M |
| June 30, 2013 | 224.15M |
| March 31, 2013 | 39.19M |
| December 31, 2012 | -123.95M |
| September 30, 2012 | -263.58M |
| June 30, 2012 | -306.58M |
| March 31, 2012 | -264.25M |
| December 31, 2011 | -198.90M |
| September 30, 2011 | -210.41M |
Free Cash Flow Range, Past 5 Years
1.582B
Minimum
Sep 2020
7.936B
Maximum
Mar 2022
3.482B
Average
2.527B
Median
Mar 2023
Free Cash Flow Benchmarks
| Vertex Pharmaceuticals Inc | 3.279B |
| Eli Lilly and Co | -3.152B |
| AbbVie Inc | 22.06B |
| Amgen Inc | 7.359B |
| Pfizer Inc | 4.793B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 1.090B |
| Cash from Investing (Quarterly) | -66.20M |
| Cash from Financing (Quarterly) | -446.10M |
| Free Cash Flow Per Share (Quarterly) | 6.827 |
| Free Cash Flow to Equity (Quarterly) | 775.90M |
| Free Cash Flow to Firm (Quarterly) | 776.20M |
| Free Cash Flow Yield | 3.56% |